Ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection BY WILL JONES 3 SEPTEMBER 2022 5:55 PM Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and […]
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM […]
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely […]
‘A combination of approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA and TGA approved Ivermectin which he uses regularly in his […]
— Drug to be given to comatose Illinois patient after docs refusedby Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 4, 2021 An Illinois judge has ordered a hospital to give ivermectin to a comatose patient with few options left. Judge James Orel of DuPage County ordered Edward-Elmhurst Hospital to allow 68-year-old COVID-19 patient […]
Taj Covi Safe Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. Taj Covi Safe Kit is currently indicated in the first line treatment for COVID-19 positive patients.
Taj Pharmaceuticals, one of the leading COVID -19 medicines Manufacturers India brings the best-quality products. The company carries the rich experience in the niche. Taj Pharmaceuticals is reputed manufacturer and COVID -19 medicines suppliers in India prefer Taj Pharmaceuticals due to the reliability and purity of products. Taj Pharmaceuticals, the well-known COVID -19 medicines Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard. As COVID -19 medicines Exporters
- Bacteria & Viruses
- Conferences & Events
- COVID-19
- Disease Info
- Disease Trends
- Divisional News
- Drug Approvals
- Drug News
- Eating Habits
- Generic
- Global Agenda
- Health & Disease
- Health & Fitness
- Health Care
- Health Kiosk
- Health News
- Healthy Food
- Industry News
- Infectious Disease
- Interactive Media
- Media
- Medical News
- Mental Health
- Press Release
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.